The Managed Care Biologics and Injectables Index
The Managed Care Biologics and Injectables Index provides a rich and informative understanding of the most important managed care market dynamics affecting biologic and injectable therapies, including:
- Trends in formulary management and benefit design, including ASP adoption
- Patient cost-sharing levels and trends
- Current commercial reimbursement rates, in different settings
- Category management trends and other management strategies
- The use of specialty pharmacy vendors and distribution dynamics
- Site-of-care dynamics
- The rise of biosimilars
- Manufacturer coupon use and impact
Click on the image below to see highlights from the latest edition of Managed Care Biologics and Injectables Index:
You can read more about the Managed Care Biologics and Injectables Index in Biotechnology Healthcare’s October 2006 issue.
For a product prospectus, or if you would like more information, contact us at strategy@zitter.com.